Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5029403 | 0.87 | SMN1; SMN2 (0.38) | CRHBPCRHR2SMN1; SMN2LMNAATM | |
| SCHEMBL5027310 | 0.85 | CRHBP (0.37) | CRHBPCRHR2SMN1; SMN2LMNAATM | |
| SCHEMBL5032009 | 0.85 | CRHBP (0.41) | CRHBPCRHR2SMN1; SMN2LMNAATM | |
| SCHEMBL5029369 | 0.69 | PDE4B (0.36) | CRHBPCRHR2SMN1; SMN2LMNAATM | |
| SCHEMBL22012817 | 0.63 | SMN1; SMN2 (0.38) | SMN1; SMN2LMNAMEN1POLBKMT2A | |
| SCHEMBL4942933 | 0.63 | SMN1; SMN2 (0.38) | SMN1; SMN2LMNAMEN1POLBKMT2A | |
| SCHEMBL11547366 | 0.61 | CYP1A2 (0.45) | SMN1; SMN2LMNAATMNPSR1MEN1 | |
| SCHEMBL3201480 | 0.61 | — | — | |
| SCHEMBL12335675 | 0.61 | EDNRA (0.38) | SMN1; SMN2ATMNPSR1MEN1KMT2A | |
| SCHEMBL28807029 | 0.60 | LMNA (0.36) | LMNATP53CYP1A2CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7279605-B2 | Synthesis of cyclopentenones | FIRMENICH SA (CH) | 2007-10-09 | — | — | US | disclosed |
| US-20070197833-A1 | SYNTHESIS OF CYCLOPENTENONES | FIRMENICH SA (CH) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197833-A1 | SYNTHESIS OF CYCLOPENTENONES | COASY, CBR3, PPIC | CRHBP 4186/4885CRHR2 3982/4885SMN1; SMN2 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.